Andrew C. Orth insider trades

Open-market stock purchases and sales by Andrew C. Orth, President & CEO at City Therapeutics, Inc, from SEC Form 4 filings since May 31, 2021.

Recent trades

DateStockTradeValue
Oct 19, 2026CTY City Therapeutics, IncBought (not open market)—

Companies traded

  • CTY City Therapeutics, Inc: other filings, last Oct 19, 2026
  • KRYS Krystal Biotech, Inc: 3 sales, last Jun 9, 2023

Get free alerts when Andrew C. Orth files a new trade →